Page 44 - Early Access Program News Today

Pherecydes Pharmas Phage Production Project (PhagoPROD) Featured in the European Commissions CORDIS Magazine Regulatory News: Pherecydes Pharma (FR0011651694 ALPHE) (Paris:ALPHE), a biotechnology company specializing in precision phage therapy to treat resistant and/or complicated bacterial infections, today announces that its PhagoPROD project, partly funded by the European Commission, has been featured in CORBIS magazine. To read the article, please click on this link CORBIS is the European C...

Tesla' has introduced the current Full Self-Driving beta software to roughly 1,000 vehicles.

Oncopeptides strengthens leadership in Europe and opens an Early Access Program in multiple myeloma News provided by Share this article STOCKHOLM, March 8, 2021 /PRNewswire/ -- Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO ), a global biotech company focused on the development of therapies for difficult-to-treat hematological diseases, today announced that it strengthens the leadership of the European operations by appointing Andrea Passalacqua as General Manager in Europe, and Pamela Bacon a...

Tesla is expanding the "Full Self-Driving" (FSD) beta it launched in October, according to CEO Elon Musk. Tesla plans to double the size of the beta test pool and eventually increase the number of vehicles in the beta tenfold.

Choice in Aging helps seniors in Solano County, beyond It’s a community-based nonprofit that has been going strong for 72 years. Choice in Aging was born in 1949 from the efforts of a physical therapist who was providing treatment for children severely disabled by polio in a church on pews, according to President and CEO Debbie Toth. The work began in Antioch and Pleasant Hill by providing adult day health care services, which includes daily programs. These programs are staffed with nurses, s...

4 weeks ago Development progress of Akida Neural Processor technology, industry partnerships and leadership expansion among highlights of the past year SAN FRANCISCO–(BUSINESS WIRE)–BrainChip Holdings Ltd. (ASX: BRN), a leading provider of ultra-low power, high-performance AI technology, ended the 2020 calendar year having made significant strides in the development of its technology backed by the launch of its Early Access Program (EAP), availability of Akid...

AIM ImmunoTech Inc's (NYSE: AIM) subsidiary, NV Hemispherx Biopharma Europe, has received formal notification from the European ...

AIM ImmunoTech Inc. AIM ImmunoTech’s Subsidiary Receives Orphan Medicinal Product Designation by the European Medicines Agency for Ampligen to Treat Pancreatic Cancer AIM ImmunoTech’s Subsidiary Receives Orphan Medicinal Product Designation by the European Medicines Agency for Ampligen to Treat Pancreatic Cancer OCALA, Fla., Feb. 24, 2021 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) today announced that its subsidiary, NV Hemispherx Biopharma Europe, has received formal no...

(MENAFN - IANS) p>New Delhi, Feb 18 (IANS) Indias homegrown digital financial services platform Paytm on Thursday announced that its wholly-owned subsidiary Paytm Money has opened Futures & Options trading for all. It aims to empower the masses with F&O trading as an important wealth management product. The company said that it received an overwhelming response for F&O trading on its platform with over 1 lakh requests for its Early Access Program. Trading is now live on the Paytm Money app an...

The bad news is, recharging is done using a Micro-USB port.